Oncologic outcomes in patients treated with endoscopic robot assisted simple enucleation (ERASE) for renal cell carcinoma: Results from a tertiary referral center.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published Date: Oct 1, 2019

Abstract

INTRODUCTION: Open Simple Enucleation (OSE) has been demonstrated to be an oncologically safe alternative to standard partial nephrectomy. We assessed the mid-term oncologic outcomes and predictors of disease recurrence in patients treated with Endoscopic Robot-Assisted Simple Enucleation (ERASE) verified through a standardized reporting system at a single institution.

Authors

  • Andrea Mari
  • Fabrizio Di Maida
    Department of Urology, University of Florence, Careggi Hospital, Florence, Italy.
  • Riccardo Tellini
    Department of Urology, University of Florence, Unit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, Florence, Italy.
  • Riccardo Campi
    Department of Urology, University of Florence, Careggi Hospital, Florence, Italy. Electronic address: riccardo.campi@unifi.it.
  • Simone Sforza
    Department of Urology, University of Florence, Unit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, Florence, Italy.
  • Andrea Cocci
    Department of Urology, Careggi Hospital, University of Florence, Florence, Italy.
  • Giampaolo Siena
  • Gianni Vittori
  • Agostino Tuccio
  • Lorenzo Masieri
  • Alberto Lapini
    Department of Urology, University of Florence, Unit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, Florence, Italy.
  • Maria Rosaria Raspollini
    Histopathology and Molecular Diagnostics. University Hospital Careggi, Florence, Italy.
  • Marco Carini
  • Andrea Minervini
    Department of Urology, Careggi Hospital, University of Florence, Florence, Italy.

Keywords

External Resources

Popular Topics
Recent Journals